Evidence map›Paper›PMID 24130252›Full record

ArticleJournal of oncology practice2013

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Andrea M Denicoff, Worta McCaskill-Stevens, Stephen S Grubbs, Suanna S Bruinooge, Robert L Comis, Peggy Devine, David M Dilts, Michelle E Duff, Jean G Ford, Steven Joffe and 18 more

2 registry-linked trialsAbstract readConsensus Development Conference, NIH
In one paragraph

Article in Journal of oncology practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 90 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03427177 nacompletednot on this mapstarted 2018, after this paper: background citation

Mychoice: Testing an Interactive mHealth Tool to Enhance Communication and Informed Decision Making About Clinical Trial Participation in Cancer Patients

TypeinterventionalSponsorFox Chase Cancer CenterRan2018 to 2020Enrolled257ConditionsConflict, Decisional ConflictArmsmychoice
NCT04426539 completednot on this mapstarted 2020, after this paper: background citation

New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study - A Study to Improve Precision in Amyloid PET Coverage and Patient Care

Typeobservational_patient_registrySponsorAmerican College of RadiologyRan2020 to 2024Enrolled6,061ConditionsAlzheimer's Disease, Dementia, Mild Cognitive Impairment
3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Priorities for Rural Lymphoma Survivors: A Qualitative Study.Clinical lymphoma, myeloma & leukemia · 2020
    Trial
  5. Trial
  6. Trial
  7. Recruiting Endometrial Cancer Survivors to Studies Examining Lifestyle Behaviors and Quality of Life: Challenges Faced and Lessons Learned.Journal of cancer education : the official journal of the American Association for Cancer Education · 2018
    Trial
  8. Trial
  9. Trial
  10. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Trial
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Andrea M DenicoffNational Cancer Institute; Education Network to Advance Cancer Clinical Trials, Bethesda; The EMMES Corporation, Rockville, MD; Delaware Cancer Consortium, Dover; Helen F. Graham Cancer Center, Newark, DE; American Society of Clinical Oncology, Alexandria, VA; Coalition of Cancer Cooperative Groups; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Cancer Information & Support Network, Auburn, CA; Oregon Health & Science University, Portland, OR; Pancreatic Cancer Action Network; Brooklyn Hospital Center, New York, NY; Massachusetts General Hospital, Boston, MA; Duke Clinical Research Institute, Durham; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; Michiana Hematology Oncology and Northern Indiana Cancer Research Consortium, South Bend, IN; Barbara Ann Karmanos Cancer Institute, Detroit, MI; University of Arizona Cancer Center, Tucson, AZ; University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland; The Ohio State University, Columbus, OH; University of Alabama at Birmingham, Birmingham, AL; Indiana University Simon Cancer Center, Indianapolis, IN; Heartland Cancer Research CCOP, St. Louis, MO; Meharry Medical College; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Worta McCaskill-Stevens
Stephen S Grubbs
Suanna S Bruinooge
Robert L Comis
Peggy Devine
David M Dilts
Michelle E Duff
Jean G Ford
Steven Joffe
Lidia Schapira
Kevin P Weinfurt
Margo Michaels
Derek Raghavan
Ellen S Richmond
Robin Zon
Terrance L Albrecht
Michael A Bookman
Afshin Dowlati
Rebecca A Enos
Mona N Fouad
Marjorie Good
William J Hicks
Patrick J Loehrer
Alan P Lyss
Steven N Wolff
Debra M Wujcik
Neal J Meropol

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMany challenges to clinical trial accrual exist, resulting in studies with inadequate enrollment and potentially delaying answers to important scientific and clinical questions.

methodsThe National Cancer Institute (NCI) and the American Society of Clinical Oncology (ASCO) cosponsored the Cancer Trial Accrual Symposium: Science and Solutions on April 29-30, 2010 to examine the state of accrual science related to patient/community, physician/provider, and site/organizational influences, and identify new interventions to facilitate clinical trial enrollment. The symposium featured breakout sessions, plenary sessions, and a poster session including 100 abstracts. Among the 358 attendees were clinical investigators, researchers of accrual strategies, research administrators, nurses, research coordinators, patient advocates, and educators. A bibliography of the accrual literature in these three major areas was provided to participants in advance of the meeting. After the symposium, the literature in these areas was revisited to determine if the symposium recommendations remained relevant within the context of the current literature.

resultsFew rigorously conducted studies have tested interventions to address challenges to clinical trials accrual. Attendees developed recommendations for improving accrual and identified priority areas for future accrual research at the patient/community, physician/provider, and site/organizational levels. Current literature continues to support the symposium recommendations.

conclusionsA combination of approaches addressing both the multifactorial nature of accrual challenges and the characteristics of the target population may be needed to improve accrual to cancer clinical trials. Recommendations for best practices and for future research developed from the symposium are provided.

Indexed as

Medical OncologyNational Cancer Institute (U.S.)Patient SelectionSocieties, MedicalAttitude of Health PersonnelClinical Trials as TopicHumansLeadershipNeoplasmsPatient Education as TopicPractice Patterns, Physicians'United States

Identifiers

PMID24130252
PMCPMC3825288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.